---
title: "Meperidine - Complete Profile"
substance: "Meperidine"
chemical_name: "1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester"
category: "Depressant"
legal_status: "Schedule II (US), Schedule II (Canada)"
description: "A synthetic opioid analgesic with unique neurotoxic properties - largely superseded by safer alternatives"
permalink: "/dyos-domain/substances/meperidine/"
---

<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Ü≠ <a href="/dyos-domain/depressants/">Depressants</a> ‚Ü≠ <span>Meperidine</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üåô Meperidine</h1>
        <h2 class="chemical-name">1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester</h2>
        
        <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="Meperidine" 
                data-category="Depressants" 
                data-chemical="1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <span class="name-tag pharmaceutical">Pethidine</span>
            <span class="name-tag brand">Demerol</span>
            <span class="name-tag brand">Pethadol</span>
            <span class="name-tag brand">Dolantin</span>
            <span class="name-tag pharmaceutical">Dolantine</span>
            <span class="name-tag pharmaceutical">Meperidine HCl</span>
            <span class="name-tag street">Demmies</span>
            <span class="name-tag street">D's</span>
            <span class="name-tag pharmaceutical">Pethidine HCl</span>
            <span class="name-tag discontinued">Operidine</span>
            <span class="name-tag discontinued">Centralgin</span>
            <span class="name-tag medical">MPP (metabolite)</span>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category depressant">Synthetic Opioid</span>
          <span class="legal-status schedule-2">Schedule II</span>
          <span class="duration short">2-4 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="{{ '/assets/substances/meperidine.jpg' | url }}" alt="Meperidine tablets and vials" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>C‚ÇÅ‚ÇÖH‚ÇÇ‚ÇÅNO‚ÇÇ</p>
            <small>Molecular Structure</small>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure Meperidine (HCl salt)</h4>
          <ul>
            <li><strong>Appearance:</strong> White, crystalline powder or colorless crystals</li>
            <li><strong>Odor:</strong> Odorless or faint characteristic odor</li>
            <li><strong>Taste:</strong> Bitter taste</li>
            <li><strong>Solubility:</strong> Freely soluble in water and alcohol</li>
            <li><strong>Melting point:</strong> 186-189¬∞C (decomposition)</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Medical/Street Forms</h4>
          <ul>
            <li><strong>Tablets:</strong> 50mg, 100mg (round, white, scored)</li>
            <li><strong>Injectable:</strong> 25mg/mL, 50mg/mL, 100mg/mL vials</li>
            <li><strong>Syrup:</strong> 50mg/5mL (banana flavored, discontinued in most countries)</li>
            <li><strong>Suppositories:</strong> Various strengths (rare)</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Quality Control Issues</h4>
          <p><strong>Medical:</strong> Pharmaceutical grade meperidine is generally pure and properly dosed</p>
          <p><strong>Street:</strong> Diverted medical supplies may be expired or improperly stored</p>
          <p><strong>Dangerous:</strong> Fake pills containing fentanyl analogs are increasingly common</p>
          <p><strong>Degradation:</strong> Meperidine degrades to toxic norpethidine over time, especially in heat</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">10-25mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">25-50mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">50-100mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">100-150mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Heavy</span>
          <span class="dose-amount">150mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Dosage Considerations</h4>
        <ul>
          <li><strong>Medical dosing:</strong> 50-150mg every 3-4 hours for pain</li>
          <li><strong>Tolerance:</strong> Develops rapidly with regular use</li>
          <li><strong>Elderly patients:</strong> Particularly vulnerable to norpethidine toxicity</li>
          <li><strong>Renal impairment:</strong> Significantly increases toxicity risk</li>
          <li><strong>Route-dependent:</strong> IV/IM doses are typically 25-50% of oral doses</li>
          <li><strong>Redosing:</strong> Not recommended due to accumulation of toxic metabolites</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>Critical Warning:</strong> Meperidine has a uniquely dangerous toxicity profile due to norpethidine accumulation. Contraindicated for chronic use or in elderly patients.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline (Oral)</h4>
        <div class="timeline-item">
          <span class="time">T+0:15-0:45</span>
          <span class="effect">Onset - initial analgesia, mild euphoria</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+0:30-2:00</span>
          <span class="effect">Peak - maximum analgesia and euphoria</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+2:00-4:00</span>
          <span class="effect">Plateau - sustained analgesia</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+4:00-6:00</span>
          <span class="effect">Comedown - return to baseline</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÖ Therapeutic Effects</h4>
          <ul>
            <li>Potent analgesia (pain relief)</li>
            <li>Euphoria and mood elevation</li>
            <li>Anxiety reduction</li>
            <li>Sedation and relaxation</li>
            <li>Suppression of cough reflex</li>
            <li>Smooth muscle relaxation</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Adverse Effects</h4>
          <ul>
            <li>Respiratory depression (dose-dependent)</li>
            <li>Nausea and vomiting</li>
            <li>Constipation</li>
            <li>Confusion and delirium</li>
            <li>Seizures (norpethidine toxicity)</li>
            <li>Serotonin syndrome risk</li>
            <li>Physical dependence and withdrawal</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>Meperidine is a synthetic opioid that primarily acts as a Œº-opioid receptor agonist, producing analgesia, euphoria, and respiratory depression. Unlike other opioids, it also has significant activity at sodium channels, NMDA receptors, and monoamine transporters, contributing to its unique side effect profile.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor">Œº-Opioid Receptor</span>
            <span class="affinity">High</span>
            <span class="effect">Primary analgesic and euphoric effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">SERT (Serotonin)</span>
            <span class="affinity">Moderate</span>
            <span class="effect">Serotonin reuptake inhibition</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">NET (Norepinephrine)</span>
            <span class="affinity">Moderate</span>
            <span class="effect">Norepinephrine reuptake inhibition</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">NMDA Receptor</span>
            <span class="affinity">Low</span>
            <span class="effect">Antagonism, contributes to analgesia</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Na+ Channels</span>
            <span class="affinity">Moderate</span>
            <span class="effect">Local anesthetic properties</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary Pathway:</strong> N-demethylation by CYP2B6, CYP3A4 ‚Üí Norpethidine (active, toxic)</p>
          <p><strong>Secondary Pathway:</strong> Hydrolysis ‚Üí Pethidinic acid (inactive)</p>
          <p><strong>Half-life:</strong> 3-5 hours (parent drug), 8-21 hours (norpethidine)</p>
          <p><strong>Bioavailability:</strong> ~50% oral (high first-pass metabolism)</p>
          <p><strong>Peak plasma:</strong> 1-2 hours after oral dose</p>
          <p><strong>Elimination:</strong> Primarily renal (norpethidine accumulates in kidney disease)</p>
        </div>

        <h4>Norpethidine Toxicity</h4>
        <div class="neurotoxicity-info">
          <p><strong>Mechanism:</strong> Norpethidine is a CNS stimulant that blocks sodium channels and has pro-convulsant properties</p>
          <p><strong>Accumulation:</strong> Half-life 2-3 times longer than parent drug, accumulates with repeated dosing</p>
          <p><strong>Toxicity:</strong> Tremor, muscle twitches, multifocal myoclonus, seizures</p>
          <p><strong>Risk factors:</strong> Renal impairment, elderly age, high doses, prolonged use</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <ul>
          <li><strong>Serotonergic activity:</strong> Risk of serotonin syndrome when combined with SSRIs/MAOIs</li>
          <li><strong>Local anesthetic:</strong> Sodium channel blockade provides additional analgesic properties</li>
          <li><strong>Short duration:</strong> Shortest-acting of the traditional opioids</li>
          <li><strong>Poor sublingual/rectal absorption:</strong> Oral or injection routes preferred</li>
          <li><strong>No active metabolites:</strong> Except norpethidine, which is problematic rather than beneficial</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Warnings</h4>
          <ul>
            <li><strong>Norpethidine toxicity:</strong> Can cause seizures even at therapeutic doses</li>
            <li><strong>MAOI interaction:</strong> Can be fatal - serotonin syndrome and excitatory toxicity</li>
            <li><strong>Respiratory depression:</strong> Especially dangerous when combined with other depressants</li>
            <li><strong>Renal impairment:</strong> Dramatically increases toxicity risk</li>
            <li><strong>Chronic use:</strong> Strongly contraindicated due to accumulating toxicity</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è Harm Reduction Measures</h4>
          <ul>
            <li><strong>Limit use:</strong> Single doses only, avoid repeated administration</li>
            <li><strong>Kidney function:</strong> Ensure normal renal function before use</li>
            <li><strong>Drug interactions:</strong> Avoid MAOIs, SSRIs, and other serotonergic drugs</li>
            <li><strong>Age considerations:</strong> Particularly dangerous in elderly populations</li>
            <li><strong>Naloxone:</strong> Have overdose reversal available</li>
            <li><strong>Never alone:</strong> Use with sober supervision</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Absolute Contraindications</h4>
        <p><strong>Do not use if you have:</strong> Kidney disease, liver impairment, history of seizures, are taking MAOIs or SSRIs, have respiratory depression, or are elderly (>65 years).</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏é Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üíÄ Deadly Combinations</h4>
          <ul>
            <li><strong>MAOIs:</strong> Serotonin syndrome, hyperthermia, seizures, death</li>
            <li><strong>Alcohol + CNS depressants:</strong> Severe respiratory depression</li>
            <li><strong>Benzodiazepines:</strong> Compounded respiratory depression</li>
            <li><strong>Barbiturates:</strong> Synergistic CNS depression</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üî¥ High Risk Combinations</h4>
          <ul>
            <li><strong>SSRIs/SNRIs:</strong> Serotonin syndrome risk</li>
            <li><strong>Tramadol:</strong> Dual serotonergic and opioid effects</li>
            <li><strong>Other opioids:</strong> Increased respiratory depression</li>
            <li><strong>Muscle relaxants:</strong> Enhanced sedation and respiratory risk</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>‚ö†Ô∏è Use With Caution</h4>
          <ul>
            <li><strong>Antihistamines:</strong> Increased sedation</li>
            <li><strong>CYP enzyme inducers:</strong> Increased norpethidine formation</li>
            <li><strong>Ritonavir:</strong> Inhibits metabolism, increases toxicity</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏é Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <h4>Global Legal Status</h4>
          <ul>
            <li><strong>United States:</strong> Schedule II controlled substance</li>
            <li><strong>Canada:</strong> Schedule II (CDSA)</li>
            <li><strong>United Kingdom:</strong> Class A controlled drug</li>
            <li><strong>Australia:</strong> Schedule 8 (controlled drug)</li>
            <li><strong>Germany:</strong> Bet√§ubungsmittel (narcotics law)</li>
            <li><strong>International:</strong> Schedule I under UN Single Convention</li>
          </ul>
        </div>
        
        <div class="therapeutic-status">
          <h4>Medical Status</h4>
          <p><strong>Current use:</strong> Largely discontinued in most countries due to safety concerns. Still occasionally used for specific indications where other opioids are contraindicated, but generally replaced by safer alternatives like morphine, oxycodone, or fentanyl.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1939</span>
          <span class="event">Synthesized by Belgian chemist Paul Janssen at Janssen Pharmaceutica</span>
        </div>
        <div class="history-event">
          <span class="year">1940s</span>
          <span class="event">Introduced as "Demerol" - marketed as a safer alternative to morphine</span>
        </div>
        <div class="history-event">
          <span class="year">1950s-70s</span>
          <span class="event">Widespread medical use for labor analgesia and post-operative pain</span>
        </div>
        <div class="history-event">
          <span class="year">1980s</span>
          <span class="event">Discovery of norpethidine toxicity leads to usage restrictions</span>
        </div>
        <div class="history-event">
          <span class="year">1982</span>
          <span class="event">MPTP contamination in illicit meperidine synthesis causes Parkinsonism</span>
        </div>
        <div class="history-event">
          <span class="year">1990s-2000s</span>
          <span class="event">Gradual phase-out from routine medical practice</span>
        </div>
        <div class="history-event">
          <span class="year">Present</span>
          <span class="event">Rarely used medically, avoided due to safety profile</span>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Medical Legacy</h4>
        <p>Meperidine represented an early attempt to create a synthetic opioid with fewer side effects than morphine. However, its unique toxicity profile, particularly norpethidine accumulation, made it a cautionary tale in pharmaceutical development. The MPTP incident also highlighted the dangers of illicit synthesis attempts.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Toxicology Studies</h4>
          <p>Ongoing research into norpethidine neurotoxicity mechanisms and potential antidotes for overdose situations.</p>
        </div>
        
        <div class="research-item">
          <h4>Historical Analysis</h4>
          <p>Retrospective studies examining the rise and fall of meperidine use in medical practice.</p>
        </div>
        
        <div class="research-item">
          <h4>Synthetic Analogues</h4>
          <p>Development of structurally related compounds without the norpethidine toxicity problem.</p>
        </div>
        
        <div class="research-item">
          <h4>Abuse Potential</h4>
          <p>Studies on meperidine's abuse liability and addiction potential compared to other opioids.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Medical Information</h4>
        <ul>
          <li><a href="https://www.drugs.com/meperidine.html">Drugs.com - Meperidine</a></li>
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/">PubMed - Norpethidine toxicity</a></li>
          <li><a href="https://www.ncbi.nlm.nih.gov/books/NBK526078/">NCBI - Meperidine</a></li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Harm Reduction</h4>
        <ul>
          <li><a href="https://harmreduction.org/">Harm Reduction International</a></li>
          <li><a href="https://www.erowid.org/chemicals/meperidine/">Erowid - Meperidine Vault</a></li>
          <li><a href="https://psychonautwiki.org/wiki/Pethidine">PsychonautWiki - Pethidine</a></li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Support & Treatment</h4>
        <ul>
          <li><a href="https://www.samhsa.gov/">SAMHSA National Helpline</a></li>
          <li><a href="https://www.na.org/">Narcotics Anonymous</a></li>
          <li><a href="https://www.smart-recovery.org/">SMART Recovery</a></li>
        </ul>
      </div>
    </div>
  </div>

</div>